BG
TECX

Bollard Group’s Tectonic Therapeutic TECX Stock Holding History

Bollard Group’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Hold
302,953
– – 0.32% 45
2026
Q1 		$9.36M Hold
302,953
– – 0.28% 48
2025
Q4 		$6.32M Hold
302,953
– – 0.16% 55
2025
Q3 		$4.75M Hold
302,953
– – 0.11% 63
2025
Q2 		$6.02M Hold
302,953
– – 0.14% 57
2025
Q1 		$5.37M Buy
+302,953
New +$9.87M 0.14% 55

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Bollard Group's TECX Position: Q2 2026 in Review

Bollard Group held its Tectonic Therapeutic (TECX) position steady in Q2 2026 at 302,953 shares worth $10.4M. The position accounts for 0.32% of the portfolio, ranked #45.

Bollard Group first reported a position in TECX in Q1 2025 and has held it in 6 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Bollard Group held 302,953 shares of Tectonic Therapeutic worth $10.4M as of Q2 2026.
  • Bollard Group left its Tectonic Therapeutic share count unchanged in Q2 2026.
  • Tectonic Therapeutic made up 0.32% of Bollard Group's portfolio in Q2 2026, its #45 holding.
  • Bollard Group first reported a position in Tectonic Therapeutic in Q1 2025 and has held it in 6 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.